⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL72335 | 0.58 | — | — | |
| SCHEMBL482580 | 0.50 | — | — | |
| Hydrochloric Acid SCHEMBL4538718 | 0.47 | — | — | |
| Hydrochloric Acid SCHEMBL28477348 | 0.47 | — | — | |
| Hydrochloric Acid SCHEMBL14910951 | 0.47 | — | — | |
| Water SCHEMBL21986451 | 0.47 | — | — | |
| Hydrochloric Acid SCHEMBL10625472 | 0.47 | — | — | |
| Hydrochloric Acid SCHEMBL28357143 | 0.47 | — | — | |
| Hydrochloric Acid SCHEMBL16398102 | 0.47 | — | — | |
| Hydrochloric Acid SCHEMBL28241565 | 0.47 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2648714-A2 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND USES THEREOF | Amira Pharmaceuticals, Inc. (US) | 2013-10-16 | — | — | EP | claimed |
| US-20130253004-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND THEIR USE IN THE TREATMENT FIBROSIS | AMIRA PHARMACEUTICALS, INC. (US) | 2013-09-26 | — | — | US | claimed |
| US-20130072490-A1 | POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | AMIRA PHARMACEUTICALS INC. (US) | 2013-03-21 | — | — | US | claimed |
| WO-2012078593-A2 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2012-06-14 | — | — | WO | claimed |
| WO-2010141768-A2 | POLYCYCLIC ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2010-12-09 | — | — | WO | claimed |
| US-9272990-B2 | Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis | AMIRA PHARMACEUTICALS, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| EP-2648714-B1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND USES THEREOF | AMIRA PHARMACEUTICALS INC (US) | 2015-11-18 | — | — | EP | disclosed |
| EP-2678344-B1 | CYCLOPROPENYLIDENE-STABILISED PHOSPHENIUM CATIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2015-09-16 | — | — | EP | disclosed |
| US-8981126-B2 | Cyclopropenylidene-stabilized phosphenium cations | Studiengesellshaft Kohle mbH (DE) | 2015-03-17 | — | — | US | disclosed |
| US-20140051870-A1 | CYCLOPROPENYLIDENE-STABILIZED PHOSPHENIUM CATIONS | STUDIENGESELLSCHAFT KOHLE GGMBH (DE) | 2014-02-20 | — | — | US | disclosed |
| EP-2678344-A2 | CYCLOPROPENYLIDENE-STABILISED PHOSPHENIUM CATIONS | Studiengesellschaft Kohle mbH (DE) | 2014-01-01 | — | — | EP | disclosed |
| EP-2648714-A2 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND USES THEREOF | Amira Pharmaceuticals, Inc. (US) | 2013-10-16 | — | — | EP | disclosed |
| US-20130253004-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND THEIR USE IN THE TREATMENT FIBROSIS | AMIRA PHARMACEUTICALS, INC. (US) | 2013-09-26 | — | — | US | disclosed |
| WO-2012113393-A2 | CYCLOPROPENYLIDENE-STABILISED PHOSPHENIUM CATIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2012-08-30 | — | — | WO | disclosed |
| WO-2012078593-A2 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2012-06-14 | — | — | WO | disclosed |
| WO-2010141768-A2 | POLYCYCLIC ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2010-12-09 | — | — | WO | disclosed |